T1	intervention 122 131	gefitinib
T2	eligibility 728 810	women with unilateral, primary operable, ER negative invasive breast cancer â‰¥ 2 cm
T3	total-participants 1207 1210	115
T4	intervention-participants 1250 1252	59
T5	control-participants 1289 1291	56
T6	control 1308 1315	placebo
T7	outcome 1399 1414	change was seen
T8	iv-bin-abs 1418 1423	three
T9	iv-bin-percent 1451 1455	5.1%
T10	cv-bin-abs 1464 1467	two
T11	cv-bin-percent 1493 1497	3.6%
